AW
ANVS icon

Avion Wealth’s Annovis Bio ANVS Stock Holding History

Avion Wealth’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-229
Closed – – 1418
2026
Q1 		$0 Hold
229
– – ﹤0.01% 1222
2025
Q4 		$0 Buy
+229
New +$688 ﹤0.01% 1211

Other funds holding ANVS

EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Avion Wealth's ANVS Position: Q2 2026 in Review

Avion Wealth sold out of Annovis Bio (ANVS) in Q2 2026, closing a stake of 229 shares.

Avion Wealth first reported a position in ANVS in Q4 2025 and held it in 2 quarters. The position peaked at $0 in Q1 2026. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • Avion Wealth reported no remaining Annovis Bio position as of Q2 2026 after selling out during the quarter.
  • Avion Wealth sold 229 Annovis Bio shares in Q2 2026.
  • Avion Wealth first reported a position in Annovis Bio in Q4 2025 and held it in 2 quarters.
  • Avion Wealth's Annovis Bio position peaked at $0 in Q1 2026.
  • 61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.